Programmes

Name: Programmes
License: https://spdx.org/licenses/CC-BY-4.0

1 Programme found

Radiotherapy with Pembrolizumab in Metastatic HNSCC (IMPORTANCE)

Randomized phase II study of immune stimulation with Pembrolizumab and radiotherapy in second line therapy of metastatic head and neck squamous cell carcinoma.

Projects:

Randomized Phase II Study of Immune Stimulation with Pembrolizumab and Radiotherapy in Second Line Therapy of Metastatic Head and Neck Squamous Cell Carcinoma (IMPORTANCE, Keynote-717)

Web page: Not specified

Programmes

Filters ×

Filters